Spearmint Tea and PCOS / PMOS — What Science Actually Says

Spearmint tea (Mentha spicata) became a PCOS viral sensation on social media — but unusually for wellness content, it has a genuine scientific foundation. Two clinical studies show a real, if modest, anti-androgen effect. This guide examines the actual evidence, the exact numbers, realistic expectations, and where spearmint tea fits in a complete PCOS management strategy.

The social media hype and its actual scientific origin

Spearmint tea for PCOS accumulated millions of views across TikTok, Instagram, and YouTube forums — often presented as a miraculous natural alternative to pharmaceutical anti-androgen treatments. The reality is more nuanced. The scientific basis for this interest is real but extremely limited: the entire evidence base as of 2026 consists of two clinical studies, both by the same research group and conducted in Turkey and the UK.

The first was Akdoğan et al. 2007 — a pilot study in 21 women with hirsutism who drank spearmint tea twice daily for just 5 days. The study found a modest reduction in free testosterone with a corresponding increase in LH and FSH, suggesting a central or peripheral anti-androgenic effect. These preliminary results were interesting enough to motivate a larger follow-up.

The second was Grant P. 2010 — a randomized controlled trial in 42 women, running for 30 days, which is the foundation of virtually everything cited about spearmint tea and PCOS. These 2 studies represent the entirety of the direct clinical evidence as of 2026. No larger, longer, or independently replicated RCT has been published. This does not invalidate the finding — it does mean the evidence base is narrow and that extrapolation beyond what was measured should be done with appropriate caution.

The social media context is worth acknowledging: spearmint tea PCOS content is unusually grounded for a wellness trend — it points to a real mechanism and a real study. But the gap between "one 30-day RCT in 42 women" and "drink this for your PCOS" is large, and understanding that gap is essential to using this approach rationally. Sources: Akdoğan et al. 2007, Phytotherapy Research; Grant P. 2010, Phytotherapy Research.

The proposed biological mechanism

Mentha spicata (spearmint) contains a range of bioactive compounds: limonene (a monoterpene), rosmarinic acid (a polyphenol with demonstrated anti-inflammatory and antioxidant properties), flavonoids (including luteolin and apigenin), and various other terpenoids including carvone (the primary odorant component, distinguishing it from peppermint's menthol).

The proposed anti-androgenic mechanisms are multiple and not fully characterized. The most likely pathways include: partial inhibition of 5-alpha-reductase activity (reducing testosterone-to-DHT conversion), reduction of testosterone-androgen receptor binding affinity (competitive or allosteric inhibition at the receptor level), and possible modulation of the hypothalamic-pituitary-ovarian axis — the Grant 2010 RCT found significant increases in both LH and FSH in the spearmint group, which is unexpected if the effect were purely peripheral. This central axis effect suggests spearmint may modulate GnRH signaling, though the mechanism is not elucidated.

Rosmarinic acid in particular has shown anti-androgenic properties in cell culture and animal studies. Luteolin has demonstrated 5-alpha-reductase inhibiting properties in vitro. However, the clinical relevance of individual compound effects — as opposed to whole-tea matrix effects — has not been established in human PCOS studies. Sources: Grant P. 2010; Akdoğan et al. 2007; Rocha et al. 2011 (polyphenols and androgen receptors).

The Grant 2010 RCT — exact numbers and limitations

The Grant 2010 RCT (Phytotherapy Research) remains the most rigorous evidence available. Design: 42 women with hirsutism, either from PCOS (n=25) or idiopathic (n=17). Participants were randomized to drink spearmint herbal tea (2 cups/day, Mentha spicata, 30 days) or chamomile tea as an active control (same volume, similar ritual, but without anti-androgenic properties).

Key results at 30 days:

Free testosterone: decreased by 29.6% in the spearmint group versus 1.2% in the chamomile group (statistically significant, p < 0.05). This is a meaningful reduction for a dietary intervention.

Total testosterone: decreased by approximately 12% in the spearmint group — this was a trend but did not reach statistical significance (p = 0.06), likely due to the small sample size.

LH (luteinizing hormone): increased by 67% in the spearmint group versus chamomile (p < 0.05).

FSH (follicle-stimulating hormone): increased by 28% in the spearmint group (p < 0.05).

Ferriman-Gallwey hirsutism score: modest but statistically significant improvement in the spearmint group (patient-reported subjective reduction in hair growth). Note that 30 days is too short to observe meaningful objective hirsutism changes — the follicular cycle requires 3–6 months for new hair growth to reflect hormonal changes.

Limitations that are critical to acknowledge: sample size is 42 women (25 with PCOS); study duration is 30 days — far too short to evaluate long-term effects on hirsutism, cycles, or fertility; no follow-up after study end; no data on acne, cycle regularization, or fertility outcomes; results have not been replicated by an independent research group; no dose-response data (higher doses were not tested); no data on long-term use. Source: Grant P. 2010, Phytotherapy Research, vol. 24(2): 186–188.

Effect on hirsutism — modest but real, in context

To understand what a 29.6% reduction in free testosterone means clinically for hirsutism, it helps to compare it to established medical treatments using a consistent framework. Hirsutism improvement is measured on the Ferriman-Gallwey (FG) scale (0–36, higher = more hirsutism) or as percentage reduction in hair growth rate.

Spironolactone 100 mg/day at 6 months: 60–70% reduction in Ferriman-Gallwey score in most RCTs. Dramatic, clinically visible results for most women within 6 months. Standard of care for moderate to severe hirsutism.

Anti-androgen combined oral contraceptive (cyproterone acetate + ethinyl estradiol, or drospirenone + EE): 40–60% FG score reduction at 6 months. Equally effective for most women who are suitable candidates.

Spearmint tea 2 cups/day: based on the free testosterone reduction observed, estimated clinical hirsutism improvement is below 20% at one month. Long-term data beyond 30 days is absent. The improvement in subjective hair perception in Grant 2010 was documented but the absolute FG score changes were small and difficult to generalize.

The appropriate positioning: spearmint tea produces a real but modest anti-androgen effect — roughly 3–4× weaker than first-line medical treatments at equivalent time points. For mild hirsutism (FG score below 8) or for women who prefer to avoid prescription medications, it is a rational complementary approach. For moderate to severe hirsutism causing significant distress or impacting quality of life, it is not adequate as a sole treatment. Sources: Grant 2010; Azziz 2003 (spironolactone hirsutism RCTs); ESHRE 2023.

Safety, dosing, timing, and potential interactions

At the doses studied — 2 cups per day of Mentha spicata tea — spearmint has an excellent safety profile with no clinically significant adverse effects documented in either study. It is a food-grade herb widely consumed globally for centuries.

Specific cautions: Women with gastroesophageal reflux disease (GERD) should be aware that mint (including spearmint) relaxes the lower esophageal sphincter, potentially worsening acid reflux symptoms. If you experience reflux after drinking spearmint tea, this is the likely mechanism — consider reducing dose or discontinuing. High-dose spearmint during pregnancy is not recommended (emmenagogue properties at high doses); normal dietary quantities are generally considered safe. No documented pharmacokinetic drug interactions at dietary doses have been established, but this has not been formally studied. Given that spearmint modestly affects androgen metabolism, caution with concurrent hormone therapies is theoretical but has not been studied. Sources: Grant 2010; EMA (European Medicines Agency) herb monograph guidance; Akdoğan 2007.

How to prepare spearmint tea — practical guide

The preparation details matter for maintaining the active compound content of the tea. Here is the protocol consistent with the studies:

Fresh spearmint: 8–10 fresh Mentha spicata leaves per cup. Place in a mug or teapot. Pour water heated to approximately 90°C (just below boiling — fully boiling water can degrade heat-sensitive polyphenols including rosmarinic acid). Steep covered for 5–7 minutes. Strain and drink. Do not add sugar or honey, as these affect the metabolic picture in PCOS; a small amount of lemon juice is acceptable.

Dried spearmint: 1 heaped teaspoon (approximately 1 gram) to 1 tablespoon of dried Mentha spicata leaves per 250 mL of 90°C water. Same steeping protocol. Dried leaves should be stored in an airtight container away from light to preserve active compounds.

Timing: 2 cups per day — one in the morning (after breakfast to avoid any gastric irritation) and one in the mid-afternoon. This matches the Grant 2010 protocol.

Iced spearmint tea: prepare as above with hot water, allow to cool to room temperature, then refrigerate. Consume within 24 hours. The active compounds are stable in the refrigerated state for this duration.

Capsule extracts: standardized spearmint extract capsules exist but their concentrations and bioavailability vary significantly between products. The clinical studies used tea prepared from the whole dried leaf — this is the studied form and the most reliable way to ensure phytochemical composition approximates what was tested. Until standardized extracts have been tested in clinical trials, the whole-leaf tea preparation is preferred. Sources: Grant 2010 methods; Akdoğan 2007.

Anti-androgen comparison — spearmint tea in context

Sources: Grant 2010; Azziz 2003; ESHRE 2023; Unfer 2017 (inositol meta-analysis); Endocrine Society 2024.

Where spearmint tea actually fits in PCOS management

Spearmint tea occupies a specific and legitimate niche in the PCOS management landscape — provided its role is clearly defined and expectations are calibrated appropriately.

It is a reasonable first approach for: women with mild PCOS symptoms (mild hirsutism, mild acne, slightly irregular cycles) who want to start with lifestyle and dietary modifications before pursuing prescription medications; women who prefer to avoid pharmaceutical anti-androgens due to concerns about contraception requirements, side effects, or cost; women who are currently trying to conceive (spearmint tea has no known contraindications in fertility-seeking women, unlike spironolactone); women who have already optimized diet, exercise, and inositol supplementation and want to add a low-risk complementary approach.

It should not be positioned as a replacement for: spironolactone or anti-androgen OCP for moderate to severe hirsutism or acne where there is documented distress or quality-of-life impact; medical PCOS management when metabolic complications (insulin resistance, dyslipidemia, hypertension) are present; fertility treatments when anovulation is the primary concern.

Combinations can be logical: spearmint tea + inositol, for example, addresses androgenism from two different angles (central/receptor-level via spearmint, insulin-resistance pathway via inositol) with no known interactions and excellent safety profiles. This combination has not been formally studied as a combined regimen, but the individual safety profiles support concurrent use. Sources: ESHRE 2023 lifestyle chapter; Unfer 2017; Grant 2010.

Open research questions and what future studies should address

The spearmint tea evidence base would be dramatically strengthened by several types of additional research. A large-scale RCT (n > 200) with longer follow-up (6–12 months) examining not just hormonal markers but clinical outcomes — hirsutism score improvement, acne grade, cycle regularity, HOMA-IR changes — would address the most critical gaps. Studies comparing different doses (1 cup, 2 cups, 4 cups per day) would define the dose-response relationship. A comparison against a validated active control (inositol or low-dose spironolactone) would contextualize the clinical magnitude of effect. Independent replication by research groups not affiliated with the original investigators is needed to confirm findings. Until these studies are conducted, the evidence base supports cautious, appropriately framed use — not the uncritical enthusiasm that characterizes most social media coverage of the topic. Sources: Grant 2010; Akdoğan 2007.

Frequently asked questions about spearmint tea and PCOS

Does spearmint tea really work for PCOS?

Modest documented effect: the Grant 2010 RCT found free testosterone reduced by 29.6% in 42 women over 30 days, with increases in LH and FSH. Real but substantially weaker than medical treatments. A reasonable complementary approach for mild symptoms or as a complement to medication.

How many cups per day and for how long?

2 cups per day (1 tablespoon dried or 5–6 fresh Mentha spicata leaves, 250 mL at 90°C, steep 5–7 minutes) for at least 30 days — the protocol from the Grant 2010 RCT. Long-term duration beyond 30 days has not been formally studied but the safety profile supports continued use.

Are there side effects?

Very well tolerated at 2 cups per day. Main caution: GERD (relaxes esophageal sphincter). High doses during pregnancy are not recommended. No documented drug interactions at dietary doses.

Can spearmint tea replace spironolactone for hirsutism?

No. Anti-androgen effect is approximately 3–4× weaker. For moderate to severe hirsutism, medical treatment is appropriate. Spearmint tea is a reasonable complement or alternative only for mild cases.

Spearmint (Mentha spicata) vs peppermint (Mentha piperita) — are they interchangeable?

No — different plants, different phytochemical profiles. Only Mentha spicata has been studied for PCOS. Peppermint has different active compounds and has not been studied for this purpose. Do not substitute peppermint and expect the same effect.

Does spearmint tea help with PCOS acne or cycle irregularity?

Insufficient direct evidence. No study has specifically evaluated acne or cycle regularization outcomes. Theoretically possible via androgen reduction, but this has not been formally demonstrated. Do not rely on spearmint tea as a primary intervention for acne or cycle irregularity.

General information only. This content does not constitute medical advice. Consult a healthcare provider before making changes to your PCOS management. Sources: Grant P. 2010 (Phytotherapy Research, vol. 24(2): 186–188); Akdoğan M. et al. 2007 (Phytotherapy Research, vol. 21(5): 444–447); ESHRE/Monash 2023 International Evidence-Based Guideline on PCOS. See our scientific sources page.